compound tirzepatide vs compound semaglutide Troubling Findings in Study of GLP-1 Compounders FDA says 'no clinical need'

The GLP-1 analogs liraglutide and semaglutide reduce atherosclerosis in apoE

Across 338 participants over 48 weeks, the cardiovascular risk markers showed consistent improvement across all dose groups

Even modest BP improvements add to cardiovascular benefit

Staying hydrated and adjusting your diet can often alleviate discomfort

A Novel Target and Mechanism of Action Tackling Heart Failure A recent example of a covalent compound outside oncology is Syntaras LOXL2 (lysyl oxidase-like 2) inhibitor SNT-5382

Beyond the pancreas, GLP-1Rs are also present in the gastric mucosa of the human stomach (Broide et al., 2013) and within enteric neurons distributed throughout the intestine (Richards et al., 2014